Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker. Tang Y, Lei Y, Gao P, Jia J, et al. BMC Cancer 2023;23:328.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tang Y, Lei Y, Gao P, Jia J, et al. Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker. BMC Cancer 2023;23:328.
PMID: 37038185